Could This Be the Next Big Trend in the Cannabis Industry?

OgraniGram Holdings Inc (TSX:OGI)(NASDAQ:OGI) is an example of a cannabis company that has looked to differentiate itself from its competition by investing in what could be a huge segment of the market.

| More on:

The edibles market is just months away from going live in Canada. However, if it’s anything like last year’s marijuana launch, consumers and investors alike could be disappointed.

Supply is still an issue and the retail market is still not operating anywhere near where it could be. That’s why it may come as no surprise that many consumers are still purchasing pot from the black market — and why that’s not likely to stop anytime soon.

However, purchasing from the underground exposes consumers to risks, and one alternative is to make cannabis products at home. With prices for pot being expensive in retail pot shops and consumers having to pay taxes on it, there’s definitely an incentive for consumers to find alternatives.

While those options are normally often limited to growing flower, there are even ways consumers can make edibles and their own cannabis-infused gummies.

Company gets around cannabis restrictions with kit that requires key ingredient

B.C.-based Paracanna sells consumers a kit where they can simply add cannabis to produce a variety of infused gummy candies. While perhaps not offering as many flavours as what consumers could get in the retail market, the company still gives users many options.

The market for this type of product is sure to soar with the launch of edibles, especially if consumers get turned off at the high price points. There are many kits online when it comes to growing and making cannabis.

In addition, there are hundreds of cannabis cookbooks on Amazon that can help consumers make their own infused products. Whether it’s growing the flower itself or making edibles, there could be lots of demand from consumers seeking cheaper options for making cannabis products.

Why finding a niche is important for cannabis companies

The number of cannabis companies popping up in the industry is going to mean that trying to get market share is will prove challenging. That’s where finding a more specialized area to focus on could be advantageous.

OrganiGram Holdings Inc (TSX:OGI)(NASDAQ:OGI) is a great example of a company that has looked to a specific segment where it can dominate with fewer competitors than in a more generic space.

The company invested in a product line earlier this year that will help OrganiGram produce quality chocolate cannabis products. By tapping into the popularity of chocolate, OrganiGram could end up producing products that can appeal to both cannabis and chocolate lovers.

For the company, it’s a clever way to tap into what could be a very profitable segment of the market while not having to worry about competing head-on with a growing number of competitors.

It wouldn’t be surprising to witness other companies follow in the footsteps of Organigram, especially if they get squeezed out of larger segments and struggle financially.

With minimal barriers to entry in this industry, finding a way for a company to differentiate itself from its peers is going to be paramount in being able to not only grabbing market share, but also being able to post a profit as well.

OrganiGram’s venture into chocolate could prove to be a big winner, and focusing on do-it-yourself cannabis kits could be another area for companies to set their sights on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor David Jagielski has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »